GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Cardia Bioplastics Ltd (ASX:CNN) » Definitions » Gross Profit

Cardia Bioplastics (ASX:CNN) Gross Profit : A$2.70 Mil (TTM As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Cardia Bioplastics Gross Profit?

Cardia Bioplastics's gross profit for the six months ended in Dec. 2023 was A$1.09 Mil. Cardia Bioplastics's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was A$2.70 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Cardia Bioplastics's gross profit for the six months ended in Dec. 2023 was A$1.09 Mil. Cardia Bioplastics's Revenue for the six months ended in Dec. 2023 was A$6.19 Mil. Therefore, Cardia Bioplastics's Gross Margin % for the quarter that ended in Dec. 2023 was 17.58%.

Cardia Bioplastics had a gross margin of 17.58% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

During the past 13 years, the highest Gross Margin % of Cardia Bioplastics was 18.98%. The lowest was -0.73%. And the median was 12.05%.


Cardia Bioplastics Gross Profit Historical Data

The historical data trend for Cardia Bioplastics's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardia Bioplastics Gross Profit Chart

Cardia Bioplastics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.93 3.69 5.71 4.07 3.15

Cardia Bioplastics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.55 1.52 1.53 1.62 1.09

Competitive Comparison of Cardia Bioplastics's Gross Profit

For the Packaging & Containers subindustry, Cardia Bioplastics's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cardia Bioplastics's Gross Profit Distribution in the Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Cardia Bioplastics's Gross Profit distribution charts can be found below:

* The bar in red indicates where Cardia Bioplastics's Gross Profit falls into.



Cardia Bioplastics Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Cardia Bioplastics's Gross Profit for the fiscal year that ended in Jun. 2023 is calculated as

Gross Profit (A: Jun. 2023 )=Revenue - Cost of Goods Sold
=22.836 - 19.691
=3.15

Cardia Bioplastics's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=6.193 - 5.104
=1.09

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$2.70 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Cardia Bioplastics's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=1.09 / 6.193
=17.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Cardia Bioplastics  (ASX:CNN) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Cardia Bioplastics had a gross margin of 17.58% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage


Cardia Bioplastics Gross Profit Related Terms

Thank you for viewing the detailed overview of Cardia Bioplastics's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Cardia Bioplastics (ASX:CNN) Business Description

Traded in Other Exchanges
Address
247 Ferntree Gully Road, Unit 1, Mount Waverley, Melbourne, VIC, AUS, VIC 3149
SECOS Group Ltd is an Australian developer and manufacturer of sustainable packaging materials. . Business operating segment includes the manufacture and distribution of polyethylene films, renewable resource-based resins, and finished products. It supplies proprietary biodegradable resins, packaging products cast films to a customer base spread globally.SECOS Global Application Development Centre is in Australia. Product Development Centre and manufacturing plant for resins and finished products in China and resins plant in Malaysia. It also has manufacturing plants for cast films in Malaysia. It conducts sales via geographical regions that include Australia, Asia, America, Europe, and Africa. Asia generates maximum revenue for the company.

Cardia Bioplastics (ASX:CNN) Headlines

No Headlines